CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
CARE1 Pragmatic Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Real-World Use of Nivolumab for the Treatment of Patients With Metastatic Upper Gastrointestinal Cancer in Canada
- Status
- COMPLETED
- Phase
- N/A
Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada
- Status
- COMPLETED
- Phase
- N/A
ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE1
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
- Status
- RECRUITING
- Phase
- PHASE3
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
- Status
- SUSPENDED
- Phase
- PHASE2
Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Repositioning Immunotherapy in VetArans With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of BND-35 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Status
- RECRUITING
- Phase
- PHASE2
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2